C81.21
Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Mixed cellularity Hodgkin lymphoma is a subtype of Hodgkin lymphoma, a type of cancer originating from white blood cells called lymphocytes. This form primarily affects lymph nodes in the head, face, and neck regions. Characterized by a diverse mix of cellular components, it is one of the more common classifications of Hodgkin lymphoma and typically impacts middle-aged and older adults. Recognizing its features and understanding available treatment options can be crucial for affected individuals and their caregivers.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Family history of lymphoma may increase risk. Immune system dysfunction: Conditions that weaken the immune response, such as HIV infection, may elevate risk. Viral infections: Certain viruses, like Epstein-Barr virus (EBV), have been linked to Hodgkin lymphoma. Environmental exposures: Though less clear, exposure to certain chemicals or radiation may contribute. Age-related factors: The incidence tends to peak in young adulthood and in older age groups.
Key Symptoms: Swollen lymph nodes: Often painless lumps in the neck, face, or other parts of the head. Fever: Persistent or recurrent fever without an obvious infection. Night sweats: Severe sweating that often soaks clothing. Unexplained weight loss: Significant loss of weight over a short period. Fatigue: Persistent tiredness not alleviated by rest. Itching: Generalized or localized itching skin sensations. Pain or discomfort: Unusual pain when lymph nodes are enlarged. Others: Loss of appetite, malaise, or localized symptoms depending on lymph node involvement.
Diagnostic & Treatment
Diagnosis Path: Physical examination: Initial assessment of lymph node swelling and associated symptoms. Imaging tests: PET scans, CT scans, to determine the extent and location of disease. Biopsy: Removal of affected lymph node tissue for microscopic examination to confirm diagnosis and subtype. Laboratory studies: Blood tests to evaluate overall health and identify any related issues. Staging procedures: Additional imaging and procedures to determine the disease stage according to established classification systems.
Treatment Protocols: Chemotherapy: Use of anticancer drugs to destroy cancer cells, often involving ABVD regimen (Adriamycin, Bleomycin, Vinblastine, Dacarbazine). Radiation therapy: Targeted radiation to affected lymph nodes to eliminate remaining cancer cells post-chemotherapy or as an initial treatment. Immunotherapy: Treatments designed to boost the body's immune response against cancer, including newer agents for relapsed disease. Stem cell transplant: For refractory or relapsed cases, high-dose chemotherapy followed by stem cell rescue. Supportive care: Managing side effects, infections, and maintaining overall health during treatment.
Clinical Advice & FAQs
Billing Guidance
Is C81.21 a billable ICD-10 code?
Yes, C81.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.21?
Clinical documentation must specify the nature of Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference